Bionomics shares are trading lower after the company announced an update on its α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator collaboration with Merck.
Portfolio Pulse from Benzinga Newsdesk
Bionomics shares are trading lower following an update on its collaboration with Merck on the α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator.
September 14, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bionomics shares are trading lower after the company announced an update on its collaboration with Merck.
The news directly mentions Bionomics and its collaboration with Merck. The announcement of the update has led to a decrease in Bionomics' share price, indicating a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Merck is collaborating with Bionomics on the α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator.
Merck is mentioned as a collaborator with Bionomics. However, the news does not indicate any direct impact on Merck's share price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50